On August 18, 2015, the FDA proudly announced that they had approved (after 2 previous rejections) a new drug whose generic name is flibanserin (Addyi will be the brand name when it comes to your local drug store in mid-October). The only drug that Sprout Pharmaceuticals has ever marketed, flibanserin is purported to treat a “disease” called hypoactive sexual desire disorder (HSDD).
The drug has been approved only for premenopausal women. The company will offer the drug in a 100 mg dose, to be swallowed once per night, no matter if sexual encounter is anticipated or not. This pill is not a female Viagra!